Psychiatric symptoms in Parkinson's disease.

被引：6

作者：

Anderson K.E. ^{[1
]}

Weiner W.J. ^{[1
]}

机构：

[1] Department of Neurology, Movement Disorders, University of Maryland, School of Medicine, 22 South Greene Street, Baltimore, 21201, MD

来源：

Current Neurology and Neuroscience Reports | 2002年 / 2卷 / 4期

关键词：

Clozapine; Anxiety Disorder; Risperidone; Olanzapine; Quetiapine;

D O I：

10.1007/s11910-002-0005-6

中图分类号：

学科分类号：

摘要：

Aside from the well-known triad of resting tremor, postural instability, and bradykinesia, Parkinson's disease (PD) patients may also develop psychiatric illness as a part of their disease. The psychiatric symptoms may be as disabling as the movement disorder, but are often amenable to treatment. We review the most recent investigations of mood disorders, anxiety disorders, and hallucinations/ psychosis in PD. We then highlight new treatment studies for hallucinations/psychosis in PD.

引用

页码：303 / 309

页数：6

共 50 条

[21] Pharmacological interventions for psychosis in Parkinson's disease patients [J].

Friedman, Joseph H. .

EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (05) :499-505

[22] Clozapine Is Severely Underused in Parkinson's Disease Patients [J].

Friedman, Joseph H. .

MOVEMENT DISORDERS CLINICAL PRACTICE, 2022, 9 (08) :1021-1024

[23] Parkinson's disease psychosis 2010 A review article [J].

Friedman, Joseph H. .

PARKINSONISM & RELATED DISORDERS, 2010, 16 (09) :553-560

[24] Psychosis in Parkinson's disease [J].

Marsh L. .

Current Treatment Options in Neurology, 2004, 6 (3) :181-189

[25] Psychosis in Parkinson's Disease [J].

Remz, Matthew ;

Salinas, Meagen .

PSYCHIATRIC ANNALS, 2020, 50 (03) :112-119

[26] Brief commentary: Under-recognition of underuse of clozapine in treating psychotic symptoms in Parkinson's disease [J].

Friedman, Joseph H. .

SCHIZOPHRENIA RESEARCH, 2024, 268 :282-284

[27] D-serine adjuvant treatment alleviates motor and behavioural symptoms in idiopathic Parkinson's disease [J].

Heresco-Levy, U. ;

Javitt, D. C. ;

Gelfin, Y. ;

Kaufman, Y. ;

Levin, R. ;

Korn-Lubetzki, I. ;

Bloch, B. ;

Wolosker, H. ;

Kremer, I. .

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 :S255-S256

[28] Systematic Review on Parkinson's Disease Medications, Emphasizing on Three Recently Approved Drugs to Control Parkinson's Symptoms [J].

Sivanandy, Palanisamy ;

Leey, Tan Choo ;

Xiang, Tan Chi ;

Ling, Tan Chi ;

Wey Han, Sean Ang ;

Semilan, Samantha Lia Anak ;

Hong, Phoon Kok .

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (01)

[29] The role of dopamine replacement on the behavioural phenotype of Parkinson's disease [J].

Alobaidi, Hajar ;

Pall, Hardev .

BEHAVIOURAL NEUROLOGY, 2013, 26 (04) :225-235

[30] Evidence for the use of pimavanserin in the treatment of Parkinson's disease psychosis [J].

Sarva, Harini ;

Henchcliffe, Claire .

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2016, 9 (06) :462-473

← 1 2 3 4 5 →